NCT02402361View on ClinicalTrials.gov

Understanding Risk Factors and Determinants for Neuropathic Pain

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

July 30, 2020

Study Completion Date

March 1, 2021

Conditions
Diabetic Neuropathy
Trial Locations (1)

31096

Rambam Medical Center, Haifa

All Listed Sponsors
collaborator

European Union

OTHER

lead

Rambam Health Care Campus

OTHER

NCT02402361 - Understanding Risk Factors and Determinants for Neuropathic Pain | Biotech Hunter | Biotech Hunter